A citation-based method for searching scientific literature

Qing Zhang, Shao-zheng Liu, Qing Zhang, Yan-xing Guan, Qing-jie Chen, Qin-yao Zhu. Cell Physiol Biochem 2016
Times Cited: 35







List of co-cited articles
241 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
51

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
543
34

Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Bela Bendlová, Linwah Yip, Caterina Mian,[...]. J Clin Oncol 2015
296
34


The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim,[...]. Cancer 2012
288
25

BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Carol Li, Kathleen C Lee, Eric B Schneider, Martha A Zeiger. J Clin Endocrinol Metab 2012
162
22

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
Ralph P Tufano, Gilberto V Teixeira, Justin Bishop, Kathryn A Carson, Mingzhao Xing. Medicine (Baltimore) 2012
198
22

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
382
20

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.
Fei Li, Guangqi Chen, Chunjun Sheng, Aaron M Gusdon, Yueye Huang, Zhongwei Lv, Huixiong Xu, Mingzhao Xing, Shen Qu. Endocr Relat Cancer 2015
70
17

Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.
Jae Yun Lim, Soon Won Hong, Yong Sang Lee, Bup-Woo Kim, Cheong Soo Park, Hang-Seok Chang, Jae Yong Cho. Thyroid 2013
74
17

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
732
17

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.
Mingzhao Xing, William H Westra, Ralph P Tufano, Yoram Cohen, Eli Rosenbaum, Kerry J Rhoden, Kathryn A Carson, Vasily Vasko, Alexandr Larin, Giovanni Tallini,[...]. J Clin Endocrinol Metab 2005
690
14

BRAF V600E mutation: Differential impact on central lymph node metastasis by tumor size in papillary thyroid carcinoma.
Seo Ki Kim, Jun Ho Lee, Jung-Woo Woo, Inhye Park, Jun-Ho Choe, Jung-Han Kim, Jee Soo Kim. Head Neck 2016
13
38

Lack of association of BRAF mutation with negative prognostic indicators in papillary thyroid carcinoma: the University of California, San Francisco, experience.
Christopher Gouveia, Nhu Thuy Can, Alan Bostrom, James P Grenert, Annemieke van Zante, Lisa A Orloff. JAMA Otolaryngol Head Neck Surg 2013
70
14

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
180
14

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
303
11


Molecular genetics and diagnosis of thyroid cancer.
Yuri E Nikiforov, Marina N Nikiforova. Nat Rev Endocrinol 2011
568
11

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
178
11

The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.
Gregory W Randolph, Quan-Yang Duh, Keith S Heller, Virginia A LiVolsi, Susan J Mandel, David L Steward, Ralph P Tufano, R Michael Tuttle. Thyroid 2012
405
11


The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Kuai-Lu Lin, Ou-Chen Wang, Xiao-Hua Zhang, Xuan-Xuan Dai, Xiao-Qu Hu, Jin-Miao Qu. Ann Surg Oncol 2010
117
11

BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases.
Vito Rodolico, Daniela Cabibi, Giuseppe Pizzolanti, Pierina Richiusa, Nicola Gebbia, Anna Martorana, Antonio Russo, Marco C Amato, Aldo Galluzzo, Carla Giordano. Cancer 2007
64
11

Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors.
Gabriella Pellegriti, Francesco Frasca, Concetto Regalbuto, Sebastiano Squatrito, Riccardo Vigneri. J Cancer Epidemiol 2013
657
11

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
11

BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
897
11


BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.
Dongbin Ahn, June Sik Park, Jin Ho Sohn, Jae Hyug Kim, Sun-Kyun Park, An Na Seo, Ji Young Park. Auris Nasus Larynx 2012
42
11

Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation?
Bojana Jankovic, Karen T Le, Jerome M Hershman. J Clin Endocrinol Metab 2013
141
11

Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progression.
Greta Gandolfi, Valentina Sancisi, Federica Torricelli, Moira Ragazzi, Andrea Frasoldati, Simonetta Piana, Alessia Ciarrocchi. J Clin Endocrinol Metab 2013
45
11

BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.
S Fraser, C Go, A Aniss, S Sidhu, L Delbridge, D Learoyd, R Clifton-Bligh, L Tacon, V Tsang, B Robinson,[...]. World J Surg 2016
21
19

The prevalence and prognostic value of BRAF mutation in thyroid cancer.
Electron Kebebew, Julie Weng, Juergen Bauer, Gustavo Ranvier, Orlo H Clark, Quan-Yang Duh, Daniel Shibru, Boris Bastian, Ann Griffin. Ann Surg 2007
316
11

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger,[...]. Thyroid 2009
11

Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab, Agnieszka Czarniecka,[...]. J Clin Oncol 2018
50
11

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
Paul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford,[...]. Cell 2004
8

Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC.
Jonathan R George, Ying C Henderson, Michelle D Williams, Dianna B Roberts, Hu Hei, Stephen Y Lai, Gary L Clayman. J Clin Endocrinol Metab 2015
44
8


Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
363
8

BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomas.
Valentina Sancisi, Davide Nicoli, Moira Ragazzi, Simonetta Piana, Alessia Ciarrocchi. J Clin Endocrinol Metab 2012
53
8

Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
258
8

A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up.
Raymon H Grogan, Sharone P Kaplan, Hongyuan Cao, Roy E Weiss, Leslie J Degroot, Cassie A Simon, Omran M A Embia, Peter Angelos, Edwin L Kaplan, Rebecca B Schechter. Surgery 2013
144
8

Clinical significance of the BRAF V600E mutation in multifocal papillary thyroid carcinoma in Korea.
Hwa Young Ahn, Yun Jae Chung, Byung Seup Kim, Kyung Ho Kang, Ju Won Seok, Hee Sung Kim, Sung Jun Park, Bo Youn Cho. Surgery 2014
22
13


BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Marina N Nikiforova, Edna T Kimura, Manoj Gandhi, Paul W Biddinger, Jeffrey A Knauf, Fulvio Basolo, Zhaowen Zhu, Riccardo Giannini, Giuliana Salvatore, Alfredo Fusco,[...]. J Clin Endocrinol Metab 2003
746
8

BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
Maria Rosa Pelizzo, Isabella Merante Boschin, Susi Barollo, Gianmaria Pennelli, Antonio Toniato, Laura Zambonin, Federica Vianello, Andrea Piotto, Eric Casal Ide, Costantino Pagetta,[...]. Clin Chem Lab Med 2011
46
8

Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited.
E Kebebew, P A Treseler, P H Ituarte, O H Clark. World J Surg 2001
150
8

The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors.
Sun Yi Choi, Heonsoo Park, Myung Koo Kang, Dong Kun Lee, Kang Dae Lee, Hyoung Shin Lee, Sung Won Kim, Eun Nam Lee, Jong Chul Hong. World J Surg Oncol 2013
31
9

Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?
Pamela Unger, Michelle Ewart, Beverly Y Wang, Li Gan, D Stave Kohtz, David E Burstein. Hum Pathol 2003
71
8

Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis.
Shelleg Dvorkin, Eyal Robenshtok, Dania Hirsch, Yulia Strenov, Ilan Shimon, Carlos A Benbassat. J Clin Endocrinol Metab 2013
54
8

Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Suk Kyeong Kim, Kee-Ho Song, So Duk Lim, Young Chang Lim, Young Bum Yoo, Ji Soo Kim, Tae Sook Hwang. Thyroid 2009
76
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.